Taking stock of the global marketplace, pharmaceutical executives face mounting challenges in many core economies. With public debt ratios at all-time highs, many European countries have instituted austerity measures or significant budget cuts, resulting in growing pricing pressures and restricted market access for pharmaceutical products. L.E.K. offers these three strategies to maximize value capture in increasingly access-challenged European markets:

  • Rigorous product selection
  • Commercially relevant evidence
  • Continuous differentiation
Sample Visuals

Related Insights